GlaxoSmithKline launches Mother's Horlicks in India, a powdered drink mix for pregnant and breast-feeding mothers containing Martek's docosahexaenoic acid (DHA), Martek announces June 24. Mother's Horlicks is a "small part" of the Horlicks line, but Martek believes the product "will help set the stage" for expanded food and beverage applications for other products containing DHA. Martek recorded revenues of $41.9 mil. with earnings of $3.4 mil. in its most recent quarter, with results reflecting inefficiencies in the firm's arachidonic acid (ARA) production and a loss of sales due to a fire at a N.J. manufacturing facility (1"The Tan Sheet" May 24, 2004, In Brief)...

Cipla has expanded its partnership with Alvotech to cover the commercialization of five biosimilars in Australia and New Zealand, building on an existing alliance covering South Africa and emerging markets.

Lack of official explanation about how the exchange of critical information will progress pending the launch of the EU’s medical device database, Eudamed3, has left many confused. New guidance lights the way forward.